WHO GRADE Ⅳ GLIOMA

Clinical trials for WHO GRADE Ⅳ GLIOMA explained in plain language.

Never miss a new study

Get alerted when new WHO GRADE Ⅳ GLIOMA trials appear

Sign up with your email to follow new studies for WHO GRADE Ⅳ GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New immune cell therapy tested for aggressive brain cancer

Disease control Recruiting now

This is an early-stage trial testing a new type of personalized immune cell therapy called TX103 CAR-T in adults with a specific, aggressive brain cancer (grade 4 glioma) that has returned or worsened after standard treatment. The main goal is to find a safe dose and see how well…

Matched conditions: WHO GRADE Ⅳ GLIOMA

Phase: PHASE1 • Sponsor: Tcelltech Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

WHO GRADE Ⅳ GLIOMA

Get alerted when new WHO GRADE Ⅳ GLIOMA trials appear

New immune cell therapy tested for aggressive brain cancer